Literature DB >> 14767815

Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis.

Delia Goletti1, Stefania Carrara, Donatella Vincenti, Elena Giacomini, Lanfranco Fattorini, Anna Rosa Garbuglia, Maria Rosaria Capobianchi, Tonino Alonzi, Gian Maria Fimia, Maurizio Federico, Guido Poli, Eliana Coccia.   

Abstract

Controversial results have been obtained in studies of the effect of Mycobacterium tuberculosis on human immunodeficiency virus type 1 (HIV-1) replication in cells of the macrophage lineage. In the present study, monocyte-derived macrophages (MDMs), previously incubated for 2 days with heat-inactivated M. tuberculosis, were infected with HIV-1. M. tuberculosis consistently inhibited viral replication, and a similar result also was observed in the presence of supernatants from M. tuberculosis-stimulated MDMs, which indicates that this effect was mediated by soluble factors. Although CCR5-binding chemokines were induced by M. tuberculosis stimulation, the results of neutralization experiments indicated that it is unlikely that they were responsible for viral suppression. Inhibition occurred mainly after viral entry (demonstrated by use of a vesicular stomatitis virus G-pseudotyped HIV-1 and by analysis of HIV-1 early and late reverse-transcription products). Therefore, M. tuberculosis-induced factors may inhibit in vitro HIV-1 replication in macrophages by affecting an early postentry step in the HIV-1 cycle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14767815     DOI: 10.1086/381554

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis?

Authors:  Collin R Diedrich; Joanne L Flynn
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441

2.  Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load.

Authors:  Collin R Diedrich; Joshua T Mattila; Edwin Klein; Chris Janssen; Jiayao Phuah; Timothy J Sturgeon; Ronald C Montelaro; Philana Ling Lin; Joanne L Flynn
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

3.  Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.

Authors:  C Scott Mahan; Maria Walusimbi; Denise F Johnson; Christina Lancioni; Edwin Charlebois; Joyce Baseke; Keith A Chervenak; Roy D Mugerwa; Diane V Havlir; Harriet Mayanja-Kizza; Christopher C Whalen; W Henry Boom
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

4.  Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.

Authors:  Padmini Srikantiah; Joseph K Wong; Teri Liegler; Maria Walusimbi; Harriet Mayanja-Kizza; Harriet K Kayanja; Roy D Mugerwa; Edwin D Charlebois; W Henry Boom; Christopher C Whalen; Diane V Havlir
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

5.  Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat.

Authors:  Robert J Kaner; Francisco Santiago; Franck Rahaghi; Elizabeth Michaels; John P Moore; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-05       Impact factor: 6.914

6.  Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation.

Authors:  Sushila K Nordone; Glicerio A Ignacio; Lishan Su; Gregory D Sempowski; Douglas T Golenbock; Liwu Li; Gregg A Dean
Journal:  AIDS Res Hum Retroviruses       Date:  2007-11       Impact factor: 2.205

7.  A common path to innate immunity to HIV-1 induced by Toll-like receptor ligands in primary human macrophages.

Authors:  Xingyu Wang; Wei Chao; Manisha Saini; Mary Jane Potash
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

8.  Candida albicans delays HIV-1 replication in macrophages.

Authors:  Christian Rodriguez Rodrigues; Federico Remes Lenicov; Carolina Jancic; Juan Sabatté; Mercedes Cabrini; Ana Ceballos; Antonela Merlotti; Heidi Gonzalez; Matías Ostrowski; Jorge Geffner
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

9.  Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.

Authors:  Guadalupe Andreani; Ana M Celentano; María E Solana; Silvia I Cazorla; Emilio L Malchiodi; Liliana A Martínez Peralta; Guillermina L Dolcini
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

10.  HIV-1 infection of macrophages dysregulates innate immune responses to Mycobacterium tuberculosis by inhibition of interleukin-10.

Authors:  Gillian S Tomlinson; Lucy C K Bell; Naomi F Walker; Jhen Tsang; Jeremy S Brown; Ronan Breen; Marc Lipman; David R Katz; Robert F Miller; Benjamin M Chain; Paul T G Elkington; Mahdad Noursadeghi
Journal:  J Infect Dis       Date:  2013-11-21       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.